Citadel Advisors’s Medallia, Inc. MDLA Stock Holding History

Citadel Advisors’s Portfolio MDLA Stock Details MDLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-51,000	Closed	-$1.73M	–	15501
2021 Q3	$1.73M	Sell	51,000 -54,600	-52%	-$1.82M	﹤0.01%	6737
2021 Q2	$3.56M	Buy	105,600 +17,700	+20%	+$509K	﹤0.01%	5207
2021 Q1	$2.45M	Buy	87,900 +33,200	+61%	+$1.23M	﹤0.01%	5927
2020 Q4	$1.82M	Buy	54,700 +16,800	+44%	+$536K	﹤0.01%	5529
2020 Q3	$1.04M	Sell	37,900 -37,800	-50%	-$1.15M	﹤0.01%	5962
2020 Q2	$1.91M	Buy	75,700 +24,800	+49%	+$592K	﹤0.01%	4667
2020 Q1	$1.02M	Buy	50,900 +25,000	+97%	+$672K	﹤0.01%	5304
2019 Q4	$806K	Buy	+25,900	New	+$765K	﹤0.01%	5984

Citadel Advisors's MDLA Position: Q4 2021 in Review

Citadel Advisors sold out of Medallia, Inc. (MDLA) in Q4 2021, closing a stake of 1,063,091 shares — an estimated $36M sold.

Citadel Advisors first reported a position in MDLA in Q3 2019 and held it in 7 quarters. The position peaked at $36M in Q3 2021. 0 funds tracked by Wall St. Rank hold MDLA as of Q4 2021.

Citadel Advisors reported no remaining Medallia, Inc. position as of Q4 2021 after selling out during the quarter.
Citadel Advisors sold 1,063,091 Medallia, Inc. shares in Q4 2021, an estimated $36M.
Citadel Advisors first reported a position in Medallia, Inc. in Q3 2019 and held it in 7 quarters.
Citadel Advisors's Medallia, Inc. position peaked at $36M in Q3 2021.
0 funds tracked by Wall St. Rank held Medallia, Inc. as of Q4 2021.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.